CTOs on the Move

Swift Health Systems

www.myinbrace.com

 
Swift Health Systems makes INBRACE, the most advanced orthodontic treatment in the world. INBRACE was created for orthodontists by orthodontists. Why is that important to you? Because the orthodontists who invented INBRACE have been treating patients for decades and turned their passion for patient satisfaction toward making a better solution for this multibillion dollar industry. We`re even more passionate about creating a great company where forward thinking, dynamic, hard-working individuals thrive.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Swift Health Systems raised $45M on 10/08/2019

Similar Companies

Glaukos

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.

1 800 Any lens

1 800 Any lens is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Air Liquide Canada

Virginia Home Medical

Virginia Home Medical is a Virginia Beach, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JenaValve

JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.